{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:12:43Z","timestamp":1788606763445,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine malignancy. While typically associated with a primary skin lesion, cases of occult-primary MCC are uncommon and pose significant diagnostic challenges, often leading to delays in appropriate management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 44-year-old male presented with a painless, enlarging mass in the right groin of 1 month\u2019s duration. He denied any history of preceding or concomitant skin nodules, lesions, or rashes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Pathological examination of the right inguinal mass, via initial biopsy and subsequent wide excision, demonstrated a metastatic neuroendocrine carcinoma. Comprehensive immunohistochemical profiling (CK20+, CKpan+, Syn+, cluster of differentiation 56+, thyroid transcription factor 1\u2212, with positive Merkel cell polyomavirus staining) confirmed the diagnosis of metastatic Merkel cell carcinoma. Staging positron emission tomography\/CT and subsequent imaging identified widespread metastatic disease to the pancreas, abdomen, and mediastinum without evidence of a primary cutaneous lesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent surgical excision of the symptomatic right inguinal nodal mass. Upon confirmation of widespread systemic progression, he received first-line systemic therapy with the etoposide + platinum regimen (etoposide\u2005+\u2005cisplatin) combined with the PD-1 inhibitor sintilimab, followed by second-line therapy with the folinic acid + fluorouracil + oxaliplatin regimen (oxaliplatin\u2005+\u2005fluorouracil) combined with sintilimab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The disease exhibited a highly aggressive course. Transient symptomatic relief was observed after the first cycle of first-line therapy. However, the disease progressed rapidly through both first- and second-line chemo-immunotherapy regimens. The patient died approximately 14 months after initial presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case underscores that MCC can present as metastatic carcinoma without an identifiable primary cutaneous lesion. This observation necessitates its inclusion in the differential diagnosis of metastatic neuroendocrine tumors, even in the absence of skin findings. Comprehensive immunohistochemistry, including cytokeratin 20 and Merkel cell polyomavirus status, is crucial for diagnosis. The rapid progression and poor response to combined chemo-immunotherapy in this young patient highlight the heterogeneous and often refractory nature of advanced MCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050345","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:21Z","timestamp":1788606021000},"page":"e50345","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A rare case of metastatic Merkel cell carcinoma presenting without a primary cutaneous lesion"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-2427","authenticated-orcid":false,"given":"Na","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260905","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(197811)42:5<2311::AID-CNCR2820420531>3.0.CO;2-L","article-title":"Trabecular carcinoma of the skin: an ultrastructural study.","volume":"42","author":"Tang","year":"1978","journal-title":"Cancer"},{"key":"R2-20260905","first-page":"327","article-title":"A comparison of merkel cell carcinoma and melanoma: results from the california cancer registry.","volume":"2","author":"Grabowski","year":"2008","journal-title":"Clin Med Oncol"},{"key":"R3-20260905","doi-asserted-by":"crossref","first-page":"739695","DOI":"10.3389\/fmicb.2021.739695","article-title":"From Merkel cell polyomavirus infection to merkel cell carcinoma oncogenesis.","volume":"12","author":"Krump","year":"2021","journal-title":"Front Microbiol"},{"key":"R4-20260905","first-page":"1293","article-title":"Merkel cell carcinoma: from pathobiology to clinical management.","volume":"10","author":"Farooq Baba","year":"2021","journal-title":"Biology (Basel)"},{"key":"R5-20260905","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1245\/s10434-020-08587-3","article-title":"Patterns of metastasis in merkel cell carcinoma.","volume":"28","author":"Song","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R6-20260905","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s004170050121","article-title":"Merkel cell carcinoma of the eyelid: histological and immunohistochemical features with special respect to differential diagnosis.","volume":"236","author":"Metz","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-20260905","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/s12885-024-12566-2","article-title":"Dermoscopic characteristics of Merkel cell carcinoma.","volume":"24","author":"Koumaki","year":"2024","journal-title":"BMC Cancer"},{"key":"R8-20260905","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2011.09.009","article-title":"Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.","volume":"67","author":"Foote","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R9-20260905","doi-asserted-by":"crossref","first-page":"e240002","DOI":"10.6004\/jnccn.2024.0002","article-title":"NCCN guidelines\u00ae insights: merkel cell carcinoma, version 1.2024.","volume":"22","author":"Schmults","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"R10-20260905","first-page":"85","article-title":"China anti-cancer association guideline for diagnosis and treatment of neuroendocrine neoplasms (2025 edition).","volume":"35","year":"2025","journal-title":"China Oncol"},{"key":"R11-20260905","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma.","volume":"3","author":"Becker","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R12-20260905","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamadermatol.2024.4607","article-title":"Merkel cell carcinoma and immunosuppression, UV radiation, and Merkel cell polyomavirus.","volume":"161","author":"Tribble","year":"2025","journal-title":"JAMA Dermatol"},{"key":"R13-20260905","doi-asserted-by":"crossref","first-page":"e11423","DOI":"10.1371\/journal.pone.0011423","article-title":"Merkel cell polyomavirus small T antigen mRNA level is increased following in vivo UV-radiation.","volume":"5","author":"Mogha","year":"2010","journal-title":"PLoS One"},{"key":"R14-20260905","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ijd.12091","article-title":"Evidence-based management of primary and localized Merkel cell carcinoma: a review.","volume":"52","author":"Ellis","year":"2013","journal-title":"Int J Dermatol"},{"key":"R15-20260905","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1067\/mjd.2002.125083","article-title":"Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation.","volume":"47","author":"Boyer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R16-20260905","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejso.2020.05.013","article-title":"Treatment of primary Merkel cell carcinoma: Radiotherapy can be an effective, less morbid alternative to surgery.","volume":"47","author":"Hong","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R17-20260905","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma.","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"key":"R18-20260905","first-page":"1524","article-title":"Modern diagnostics and treatment of Merkel cell carcinoma.","volume":"21","author":"Weilandt","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"R19-20260905","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.3390\/cancers14246058","article-title":"T-cell mediated immunity in merkel cell carcinoma.","volume":"14","author":"Ouyang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R20-20260905","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.3390\/ijms22168679","article-title":"T-cell responses in merkel cell carcinoma: implications for improved immune checkpoint blockade and other therapeutic options.","volume":"22","author":"Gehrcken","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R21-20260905","doi-asserted-by":"crossref","first-page":"e1338237","DOI":"10.1080\/2162402X.2017.1338237","article-title":"Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.","volume":"6","author":"Schadendorf","year":"2017","journal-title":"Oncoimmunology"},{"key":"R22-20260905","doi-asserted-by":"crossref","first-page":"1579287","DOI":"10.3389\/fonc.2025.1579287","article-title":"Case report: complete response to pembrolizumab monotherapy in a geriatric patient with metastatic Merkel cell carcinoma and TNBC.","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"},{"key":"R23-20260905","doi-asserted-by":"crossref","first-page":"e012660","DOI":"10.1136\/jitc-2025-012660","article-title":"Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.","volume":"13","author":"Ch\u2019en","year":"2025","journal-title":"J ImmunoTher Cancer"},{"key":"R24-20260905","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/1750743X.2025.2554566","article-title":"Successful treatment of localized Merkel cell carcinoma with avelumab in a patient with amyotrophic lateral sclerosis.","volume":"17","author":"Arnold","year":"2025","journal-title":"Immunotherapy"},{"key":"R25-20260905","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00403-024-02817-4","article-title":"High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization.","volume":"316","author":"Cheraghlou","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"R26-20260905","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/cam4.4562","article-title":"Merkel cell carcinoma in lymph nodes with and without primary origin.","volume":"11","author":"Fennig","year":"2022","journal-title":"Cancer Med"},{"key":"R27-20260905","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system.","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R28-20260905","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1078-0432.CCR-17-1678","article-title":"Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden, and improved survival.","volume":"24","author":"Vandeven","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R29-20260905","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2012.07.035","article-title":"Unknown primary Merkel cell carcinoma: 23 new cases and a review.","volume":"68","author":"Tarantola","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R30-20260905","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.amjsurg.2013.02.005","article-title":"A better prognosis for Merkel cell carcinoma of unknown primary origin.","volume":"206","author":"Chen","year":"2013","journal-title":"Am J Surg"},{"key":"R31-20260905","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity.","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"R32-20260905","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1158\/1078-0432.CCR-23-1957","article-title":"Characterization of immunosuppressive myeloid cells in merkel cell carcinoma: correlation with resistance to PD-1 pathway blockade.","volume":"30","author":"Tabachnick-Cherny","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R33-20260905","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2045-3701-3-29","article-title":"Creation of a Merkel cell polyomavirus small T antigen-expressing murine tumor model and a DNA vaccine targeting small T antigen.","volume":"3","author":"Gomez","year":"2013","journal-title":"Cell Biosci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:26Z","timestamp":1788606026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050345"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":33,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050345","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"2026-02-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}